Depressive Symptoms at the Muhimbili National Hospital MAT Clinic, Dar Es Salaam, Tanzania: A Cross-Sectional Study
Authors
Department of Psychiatry and Mental Health, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam (Tanzania)
Department of Psychiatry and Mental Health, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam (Tanzania)
Article Information
DOI: 10.47772/IJRISS.2026.1017PSY0008
Subject Category: Social science
Volume/Issue: 10/17 | Page No: 133-146
Publication Timeline
Submitted: 2026-02-01
Accepted: 2026-02-08
Published: 2026-02-25
Abstract
Background Globally, the number of people who use substances has rapidly increased over the past decade and has become a public health problem. Co-morbidity of mental disorders and substance use disorder has been well documented with disproportionately higher diagnosis for depression been made in patients with substance use disorders including heroin users. Limited number of studies have examined the phenomenon of symptoms of depression among MAT clients in Tanzania setting and none has proposed the probable interventions.
Broad objective To determine the prevalence and factors associated with depressive symptoms among methadone using clients attending MAT clinic at Muhimbili National Hospital in Dar es Salaam, Tanzania.
Methods Hospital based cross-sectional study was conducted using quantitative methods and utilizing the Patient Health questionnaire-9 (PHQ-9) as screeners for depressive symptoms, a semi-structured questionnaire for socio-demographic information and clinical characteristics, Adverse Childhood Experiences-10 (ACE-10) for adverse childhood experiences (ACEs) and Multidimensional Scale of Perceived Social Support (MSPSS) for perceived social support. A total of 341 methadone using clients were recruited via systematic and stratified sampling techniques. Analysis was conducted using statistical package for social sciences (SPSS) version 23. Univariate analysis, logistic regression for Bivariate and Multivariate analysis presented as Odds ratios with 95% confidence interval and p<0.05 were conducted.
Results Overall, 310 (90.9%) participants were males. Mean age was 39.37 (SD7.42) years. Prevalence of depressive symptoms was 36.7%. Risk of depressive symptoms increased by having a history of incarceration [aOR=2.87, 95%CI (1.70–4.86), ρ=0.000] and low perceived social support [aOR=4.03, 95%CI (1.78–9.15), ρ=0.001].
tailored
Keywords
Depressive symptoms, Medically Assisted Treatment (MAT)
Downloads
References
1. UNODC. World Drug Report - Executive Summary. World Drug Report. Published 2020. Accessed Jan. 10, 2020. https://wdr.unodc.org/wdr2020/field/WDR20_BOOKLET_1.pdf [Google Scholar] [Crossref]
2. Kurth A, Cherutich P, Conover R, Chhun N, Bruce RD, Lambdin B. The Opioid Epidemic in Africa and Its Impact. Curr.Addict.Rep.2018;5(4):428-453. doi:0.1007/s40429-018-0232-9 [Google Scholar] [Crossref]
3. Degenhardt L, Grebely J, Stone J, et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet. 2019;394(10208):1560-1579. doi:10.1016/S0140-6736(19)32229-9 [Google Scholar] [Crossref]
4. Isbell H, H. Vogel V. The addiction liability of methadone (amidone, dolophine, 10820) and its use in the treatment of morphine abstinence syndrome. Am J Psychiatry. 2006;105(12):909-914. doi:doi:10.1176/ajp.105.12.909 [Google Scholar] [Crossref]
5. Dole VP, Nyswander M. A Medical Treatment for Diacetylmorphine (Heroin) Addiction. J Occup Environ Med. 1966;8(4):241. doi:10.1097/00043764-196604000-00028 [Google Scholar] [Crossref]
6. Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): A review of historical and clinical issues. Mt Sinai J Med. 2000;67(5-6):347-364. [Google Scholar] [Crossref]
7. Guidance R. Comprehensive HIV Prevention for People Who Inject Drugs, Revised Guidance. Published 2010.Accessed Dec.12,2020. https://www.ghdonline.org/uploads/PEPFAR_HIV_Prevention_for_IDU.pdf [Google Scholar] [Crossref]
8. Ward J, Mattick RP, Hall W, Ward J, Mattick RP, Hall W. Quality assurance review: The effectiveness of methadone maintenance treatment : an overview. Drug Alcohol Rev. 1994;13(3):327-336. doi:doi.org/10.1080/09595239400185431 [Google Scholar] [Crossref]
9. Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575-1586. doi:10.1016/S0140-6736(13)61611-6 [Google Scholar] [Crossref]
10. Goldner EM, Lusted A, Roerecke M, Rehm J, Fischer B. Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: Systematic review and meta-analyses. Addict Behav. 2014;39(3):520-531. doi:10.1016/j.addbeh.2013.11.022 [Google Scholar] [Crossref]
11. Marta Torrens, Joan-Ignasi Mestre-Pintó and Antònia Domingo-Salvany Institut Hospital del Mar d’Investigacions Mèdiques, Barcelona S. Comorbidity Disorders in Use and Mental of Substance Europe.; 2015. doi:doi:10.2810/532790 [Google Scholar] [Crossref]
12. Parmenter J, Mitchell C, Keen J, et al. Predicting biopsychosocial outcomes for heroin users in primary care treatment : Br J Gen Pract. 2013;63(612):499-505. doi:10.3399/bjgp13X669220 [Google Scholar] [Crossref]
13. Kelly TM, Daley DC, Douaihy AB. Treatment of Substance Abusing Patients with Comorbid Psychiatric Disorders. Addict Behav. 2012;37(1):11-24. doi:10.1016/j.addbeh.2011.09.010.Treatment [Google Scholar] [Crossref]
14. Nyandindi C, Mbwambo J, McCurdy S, Lambdin B, Copenhaver M, Bruce R. Prevalence of HIV, hepatitis C and depression among people who inject drugs in the Kinondoni Municipality In Dar Es Salaam, Tanzania. Drug Alcohol Depend. 2014;140(2014):e164. doi:10.1016/j.drugalcdep.2014.02.461 [Google Scholar] [Crossref]
15. Barrot H. Lambdin, Frank Masao, Olivia Chang, Pamela Kaduri, Jessie Mbwambo, Ayoub Magimba, Norman Sabuni RDB. Methadone Treatment for HIV Prevention— Feasibility, Retention, and Predictors of Attrition in Dar es Salaam, Tanzania: A Retrospective Cohort Study. HIV/AIDS. 2014;59:735-742. doi:10.1093/cid/ciu382 [Google Scholar] [Crossref]
16. Seushi AK. Factors associated with adherence to methadone treatment among heroin users attending a methadone assisted treatment program at Muhimbili national hospital. Published online2013. http://dspace.muhas.ac.tz:8080/xmlui/bitstream/handle/123456789/1655/Adili Seushi.pdf?sequence=1&isAllowed=y [Google Scholar] [Crossref]
17. Muhimbili National Hospital. MAT Monthly Report February-2021. Unpublished Program Data.; 2021. [Google Scholar] [Crossref]
18. Ubuguyu O, Tran OC, Bruce RD, et al. Improvements in Health-related Quality of Life among Methadone Maintenance Clients in Dar es Salaam, Tanzania Omary. Int J Drug Policy. 2016;(30):74-81. doi: 10.1016/j.drugpo.2016.03.005.Improvements [Google Scholar] [Crossref]
19. Zimet GD, Dahlem NW, Zimet SG, Farley GK. The Multidimensional Scale of Perceived Social Support. J Pers Assess. 1988;52(1):30-41. doi:10.1207/s15327752jpa5201_2 [Google Scholar] [Crossref]
20. Stewart RC, Umar E, Tomenson B, Creed F. Validation of the multi-dimensional scale of perceived social support (MSPSS) and the relationship between social support, intimate partner violence and antenatal depression in Malawi. BMC Psychiatry. 2014;14(1):1-11. doi:10.1186/1471-244X-14-180 [Google Scholar] [Crossref]
21. Nakigudde J, Musisi S, Ehnvall A, Airaksinen E, Agren H. Adaptation of the multidimensional scale of perceived social support in a Ugandan setting. Afr Health Sci. 2009;9 Suppl 1(1):S35-41. [Google Scholar] [Crossref]
22. Vincent J. Felitti, MD, FACP, Robert F. Anda, MD, MS, Dale Nordenberg, MD, David F. Williamson, MS, PhD, Alison M. Spitz, MS, MPH, Valerie Edwards, BA, Mary P. Koss, PhD, James S. Marks, MD M. Relationship of Childhood Abuse and Household Dysfunction to Many of the Leading Causes of Death in Adults The Adverse Childhood Experiences (ACE) Study. Am J Prev Med. 1998;14(4):33-41. doi:10.1016/s0749- 3797(98)00017-8 [Google Scholar] [Crossref]
23. UNICEF, CDC, MUHAS. Violence Against Children in Tanzania Findings from a National Survey 2009. Published 2011. Accessed February 21, 2021. https://www.unicef.org/media/files/Violence_against_children_in_Tanzania_report.pdf [Google Scholar] [Crossref]
24. Tanzania: How abuse or support factors may influence migration to the street. Community Ment Health J. 2010;46(1):26-32. doi:10.1007/s10597-009-9196-5 [Google Scholar] [Crossref]
25. Kroenke K, Spitzer RL, Williams JBW. Validity of a Brief Depression Severity Measure Kurt. J Gen Intern Med. 2001;16(9):606-613. doi:10.1046/j.1525-1497.2001.016009606.x [Google Scholar] [Crossref]
26. McAlpine K, Henley R, Mueller M, Vetter S. A survey of street children in Northern Omoro SAO. Swahili translation and validation of the Patient Health Questionnaire-9 depression scale in the Kenyan head and neck cancer patient population. Int’l J Psychiatry Med. 2006;36(3):367-381. doi:10.2190/8w7y-0tpm-jvgv-qw6m [Google Scholar] [Crossref]
27. Smith Fawzi MC, Ngakongwa F, Liu Y, et al. Validating the Patient Health Questionnaire-9 (PHQ-9) for screening of depression in Tanzania. Neurol Psychiatry Brain Res.2019;31(November 2018):9-14. doi:10.1016/j.npbr.2018.11.002 [Google Scholar] [Crossref]
28. Jiao M. Efficacy of a Positive Psychological Intervention in Improving Mental Health Status Among Methadone Maintenance Treatment Users in Guangzhou , China — a Randomized Controlled Trial. Int J Ment Health Addict. Published online 2020. doi:10.1007/s11469-019-00206-x [Google Scholar] [Crossref]
29. Kermode M, Choudhurimayum RS, Rajkumar LS, Haregu T. Retention and outcomes for clients attending a methadone clinic in a resource ‑ constrained setting : a mixed methods prospective cohort study in Imphal , Northeast India. Harm Reduct J. Published online 2020:1-17. doi:10.1186/s12954-020-00413-z [Google Scholar] [Crossref]
30. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. 2006;166(10):1092-1097. doi:10.1001/archinte.166.10.1092 [Google Scholar] [Crossref]
31. Mughal AY, Devadas J, Ardman E, et al. A systematic review of validated screening tools for anxiety disorders and PTSD in low to middle income countries. BMC Psychiatry. 2020;20(1):1-18. doi:10.1186/s12888-020-02753-3 [Google Scholar] [Crossref]
32. Osborn TL, Venturo-Conerly KE, Wasil AR, Schleider JL, Weisz JR. Depression and Anxiety Symptoms, Social Support, and Demographic Factors Among Kenyan High School Students. J Child Fam Stud. 2020;29(5):1432-1443. doi:10.1007/s10826-019-01646-8 [Google Scholar] [Crossref]
33. National institute on drug abuse. Common Comorbidities with Substance Use Disorders.; 2018. https://www.drugabuse.gov [Google Scholar] [Crossref]
34. Yin W, Pang L, Cao X, et al. Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China. Addiction. 2014;110(1):51-60. doi:10.1111/add.12780 [Google Scholar] [Crossref]
35. Le TA, Le MQT, Dang AD, et al. Multi-level predictors of psychological problems among methadone maintenance treatment patients in difference types of settings in Vietnam. Subst Abus Treat Prev Policy. 2019;14(1):1-10. doi:10.1186/s13011-019-0223-4 [Google Scholar] [Crossref]
36. Xu Y, Zhong B, Chen W, Zhu J, Lu J. Suicidal ideation among Chinese patients : prevalence and correlates. Oncotarget. 2017;8(49):86181-86187. doi:10.18632/oncotarget.21032 [Google Scholar] [Crossref]
37. Ho YF, Ng MH, Tsai CC, et al. Major depression and related factors among heroin users who received methadone maintenance treatment in Taiwan: a case control study. J Subst Use. 2017;22(4):457-462. doi:10.3109/14659891.2015.1021866 [Google Scholar] [Crossref]
38. Bassiony MM, Youssif UM, Hussein RA, Saeed M. Psychiatric comorbidity among egyptian patients with opioid use disorders attributed to tramadol. J Addict Med. 2016;10(4):262-268. doi:10.1097/ADM.0000000000000231 [Google Scholar] [Crossref]
39. Grella CE, Karno MP, Warda US, Niv N, Moore AA. Gender and comorbidity among individuals with opioid use disorders in the NESARC study. Addict Behav. 2009;34(6-7):498-504. doi:10.1016/j.addbeh.2009.01.002 [Google Scholar] [Crossref]
40. Rosic T, Naji L, Bawor M, et al. The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: A prospective cohort study. Neuropsychiatr Dis Treat. 2017;13:1399-1408. doi:10.2147/NDT.S129480 [Google Scholar] [Crossref]
41. Roncero C, Barral C, Rodríguez- L, et al. Psychiatric comorbidities in opioid-dependent patients undergoing a replacement therapy programme in Spain: the PROTEUS study. Psychiatry Res. 2016;30(243):174-181. doi:10.1016/j.psychres.2016.06.024 [Google Scholar] [Crossref]
42. Callaly T, Trauer T, Munro L, Whelan G. Prevalence of psychiatric disorder in a methadone maintenance population. Aust N Z J Psychiatry. 2001;35(5):601-605. doi:10.1046/j.1440- 1614.2001.00916.x [Google Scholar] [Crossref]
43. Abousaeedi H, Hosseini OR, Bidaki R, et al. Viral and Psychiatric Disorders in Methadone Maintenance Therapy ( MMT ) Clients. Thrita. 2016;5(4). doi:10.5812/thrita.36365 [Google Scholar] [Crossref]
44. Saing CH, Prem K, Uk P. Prevalence and social determinants of psychological distress among people who use drugs in Cambodia. Int J Ment Health Syst. 2020;14(77):1-20. doi:10.1186/s13033-020-00411-5 [Google Scholar] [Crossref]
45. Gyawali B, Choulagai BP, Paneru DP, Ahmad M, Leppin A, Kallestrup P. Prevalence and correlates of psychological distress symptoms among patients with substance use disorders in drug rehabilitation centers in urban Nepal: A cross-sectional study. BMC Psychiatry. 2016;16(1):1-10. doi:10.1186/s12888-016-1003-6 [Google Scholar] [Crossref]
46. Wahab S, Keat TC, Azmi AD, et al. Risk of Depression Among MMT Patients : Does Coping Strategies and Perceived Social Support Play a Role ? Published online 2021. doi:10.1177/11782218211049407 [Google Scholar] [Crossref]
47. Li J, Gu J, Lau JTF, Chen H, Mo PKH, Tang M. Prevalence of depressive symptoms and associated factors among people who inject drugs in China. Drug Alcohol Depend. 2015;151:228-235. doi:10.1016/j.drugalcdep.2015.03.028 [Google Scholar] [Crossref]
48. Macmanus E, Fitzpatrick C. Alcohol dependence and mood state in a population receiving methadone maintenance treatment. Ir J Psychol Med. 2007;24(1):19-22. doi:10.1017/S0790966700010107 [Google Scholar] [Crossref]
49. Pathak N, Ojha S., Sharma V. Prevalence of depressive symptoms among the clients maintained in methadone maintenance treatment programme at Tribhuvan University Teaching Hospital . J Psychiatr Assoc Nepal. 2015;4(2):16-19. doi:10.3126/jpan.v4i2.18322 [Google Scholar] [Crossref]
Metrics
Views & Downloads
Similar Articles
- The Impact of Ownership Structure on Dividend Payout Policy of Listed Plantation Companies in Sri Lanka
- Urban Sustainability in North-East India: A Study through the lens of NER-SDG index
- Performance Assessment of Predictive Forecasting Techniques for Enhancing Hospital Supply Chain Efficiency in Healthcare Logistics
- The Fractured Self in Julian Barnes' Postmodern Fiction: Identity Crisis and Deflation in Metroland and the Sense of an Ending
- Impact of Flood on the Employment, Labour Productivity and Migration of Agricultural Labour in North Bihar